ANASA (Patients' Satisfaction With Pulmonary Diseases' Treatment)

NCT ID: NCT01475045

Last Updated: 2011-11-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1160 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-01-31

Study Completion Date

2011-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to compare patients' satisfaction from the use of three different inhalation devices by using the FSI-10 questionnaire

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients are requested to reply to FSI-10 questionnaire regarding their satisfaction from inhalation devices. Patients are on 3 different asthma inhalation devices with combination treatment (Turbuhaler, Diskus, Elpenhaler)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma Chronic Obstructive Pulmonary Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

COPD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Turbuhaler inhaler use

No interventions assigned to this group

Discus inhaler use

No interventions assigned to this group

Elpenhaler inhaler use

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients \> 18 years old, both genders who are on their inhalation treatment at least two months before study enrollment,
* Who are able to be compliant to study procedures

Exclusion Criteria

* Patients \< 18 years old,
* Patients who are on their inhalation treatment less than two months before study enrollment
* Patients who are not able to be compliant to study procedures
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Elpen Pharmaceutical Co. Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Asimina Gaga

Role: PRINCIPAL_INVESTIGATOR

7th Pulmonary Clinic, Sotiria Hospital of Athens

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

7th Pulmonary Clinic, Sotiria Hospital

Athens, , Greece

Site Status

Sotiria Hospital

Athens, , Greece

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Greece

Related Links

Access external resources that provide additional context or updates about the study.

http://www.erscongress2011.org

study design presented in European Respiratory Congress (2 thematric posters)

http://www.mednet.gr/archives/

FSI-10 questionnaire has been translated and is valid in Greek language (full article)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Sponsor ID

Identifier Type: OTHER

Identifier Source: secondary_id

20109-HAL-EL-02

Identifier Type: -

Identifier Source: org_study_id